ATP13A4 amplification has been frequently observed in patients with non‐small‐cell lung cancer ovarian cancer, cervical cancer, head and neck cancer, endometrial cancer, uterine endometrioid carcinoma, bladder cancer, melanoma, and breast cancer [17]. Here, ATP13A4 is linked to melanoma.